Flora Growth Corp. (FLGC)
9.51
+0.14
(+1.49%)
USD |
NASDAQ |
Dec 10, 16:00
9.51
0.00 (0.00%)
Pre-Market: 20:00
Flora Growth EPS Diluted (Quarterly): -9.048 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 0.0127 |
| Tharimmune, Inc. | -0.3367 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.627M |
| Revenue (Quarterly) | 9.748M |
| Total Expenses (Quarterly) | 13.38M |
| Enterprise Value | -2.876M |
| Gross Profit Margin (Quarterly) | -14.91% |
| Profit Margin (Quarterly) | -37.21% |
| Earnings Yield | -325.5% |
| Normalized Earnings Yield | -319.63 |